|
Decision
Point 8
|
The PCP now feels better about LMWHs and is ready to use them; however he has some questions about outpatient management and about the specific LMWH agents. He wants to know if any of the low molecular weight heparins has an indication from the FDA for outpatient management of deep venous thrombosis?
a)
Dalteparin
b) Enoxaparin
c)
Tinzaparin
d)
Nadroparin
e) More
than one of the above
